Innovative drug out-licensing deal count vs Clinical trial country use share in China
Innovative drug out-licensing deal count and Clinical trial country use share in China, compared over time.
Change the pair
Compare different indicators
The series
Over time
China, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
Innovative drug out-licensing deal count
Unit: count · 2 observations
Clinical trial country use share
Unit: % · 3 observations
Provenance
Where these numbers come from
Innovative drug out-licensing deal count
Total number of out-licensing transactions concluded for innovative pharmaceutical products.
2 observations in China · source organisations: NHSA
Clinical trial country use share
Percentage of total clinical trial country uses accounted for by a given region.
3 observations in China · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring